Page URL: https://www.bionews.org.uk/page_151717

New report gives guidance on genome editing for heritable diseases

7 September 2020
Appeared in BioNews 1062

Genome editing is not yet safe for creating germline changes in humans, an international commission has concluded.

The International Commission on the Clinical Use of Human Germline Genome Editing was formed to review applications of heritable human genome editing (HHGE) in humans, and to arrive at a consensus on translation from laboratory research to the clinical uses. Following an extensive review, the commission has now published a report, in which it concludes that for the time being, no human embryos or gametes whose genomes have been edited should be used to establish pregnancies.

'It came out very clearly that the science is not ready for clinical application, in fact far from it,' Professor Richard Lifton, co-chair of the commission, told the Guardian. 'There are many gaps that need to be addressed before we believe it would be reasonable to go forward with any clinical effort.'

The 18-member commission was organised by the US National Academy of Medicine, the US National Academy of Sciences, and the UK's Royal Society, in response to the genome-edited twin girls born in China in 2018 (see BioNews 977). In his controversial work, the now-imprisoned Dr He Jiankui used CRISPR to edit the genomes of human embryos and then used these embryos to establish pregnancies, in an attempt to make the resulting children resistant to HIV.

Reviewing the science available, the report gives advice to how, in future, genome editing might be performed safely in human embryos. The authors have provided a 'responsible clinical translational pathway' with comments on rationale to justify HHGE, focusing on the prevention of serious, life-shortening diseases caused by single inherited genes.

The authors also urge countries to hold 'extensive societal dialogue' before permitting germline genome editing in the clinic, and to carefully study any edited embryos both before and after implantation. Furthermore, the commission recommends the creation of an international scientific advisory panel. This panel would continue surveillance of related technologies and proposals, and would enable professionals to make anonymous reports of any secretive or otherwise questionable uses of HHGE.

'We think the bar should be high, and appropriately so,' Professor Lifton said. 'If you are going to be creating human beings, you want to know that you can reliably make the edits you're intending. If you can't do it reliably, without introducing unintended effects, you shouldn’t be going forwards.'

Comments on the report included both praise and criticism, with some arguing that the commission's recommendations may be too strict and may go beyond the commission's original scope.

'The criteria the report sets out, for the first acceptable clinical use of germline genome editing in humans, are far too narrow,' commented Sarah Norcross, director of the Progress Educational Trust, the charity which publishes BioNews. 'Furthermore, the report strays beyond its scientific remit. Much of the report – including a third of its recommendations – concerns governance, which is the focus of a separate genome editing project by the World Health Organisation.'

SOURCES & REFERENCES
Commission charts narrow path for editing human embryos
Science magazine |  3 September 2020
Gene-edited babies: Current techniques not safe, say experts
BBC News |  4 September 2020
Genome editing for heritable diseases not yet safe, report states
The Guardian |  3 September 2020
Heritable genome editing not yet ready to be tried safely and effectively in humans
The Royal Society |  3 September 2020
Heritable Human Genome Editing
National Academy of Medicine, National Academy of Sciences, and the Royal Society |  2 September 2020
New report charts a course for heritable human genome editing
Genetic Engineering and Biotechnology News |  3 September 2020
Too early to allow pregnancies with genome edited embryos, says commission
BMJ |  4 September 2020
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
12 October 2020 - by Dr Christopher Gyngell 
The transformative impact of CRISPR/Cas9 genome editing was recognised last week, with the Nobel Prize being awarded to its founders Jennifer Doudna and Emmanuelle Charpentier...
14 September 2020 - by Amarpreet Kaur 
An International Commission on the Clinical Use of Human Germline Genome Editing was assembled by the Royal Society, the US National Academy of Sciences and the US National Academy of Medicine...
29 June 2020 - by Jennifer Frosch 
CRISPR genome editing may result in unwanted heritable genetic changes, which could lead to long-term risks in a clinical context...
6 January 2020 - by Laura Riggall 
Professor He Jiankui, the Chinese scientist who created the world’s first genome-edited babies, has been sentenced to three years in prison for violating medical regulations...
19 August 2019 - by Dr Helen Robertson 
The international commission on the Clinical Use of Human Germline Genome Editing met for the first time last week to discuss the governance and use of embryo genome editing...
3 June 2019 - by Georgia Everett 
An international commission has been assembled to provide guidance on the development of therapies using human germline genome editing...
26 November 2018 - by Shaoni Bhattacharya 
The first births from genome-edited human embryos have been announced by a Chinese researcher amid widespread condemnation, and fears over safety...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.